Graham Capital Management L.P. purchased a new stake in The Beauty Health Company (NASDAQ:SKIN – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 175,660 shares of the company’s stock, valued at approximately $1,057,000.
Several other large investors also recently made changes to their positions in SKIN. Tower Research Capital LLC TRC lifted its position in Beauty Health by 172.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,666 shares of the company’s stock valued at $56,000 after acquiring an additional 4,217 shares in the last quarter. State of Wyoming raised its stake in shares of Beauty Health by 46.4% in the 4th quarter. State of Wyoming now owns 6,791 shares of the company’s stock valued at $62,000 after purchasing an additional 2,152 shares during the period. Royal Bank of Canada lifted its holdings in shares of Beauty Health by 22.8% in the third quarter. Royal Bank of Canada now owns 7,700 shares of the company’s stock valued at $91,000 after purchasing an additional 1,430 shares in the last quarter. Amundi boosted its position in shares of Beauty Health by 24.1% during the fourth quarter. Amundi now owns 9,032 shares of the company’s stock worth $92,000 after buying an additional 1,754 shares during the period. Finally, Boothbay Fund Management LLC bought a new position in shares of Beauty Health during the first quarter worth about $128,000.
Analysts Set New Price Targets
A number of research firms have weighed in on SKIN. Jefferies Financial Group downgraded Beauty Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Canaccord Genuity Group increased their target price on shares of Beauty Health from $2.50 to $3.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $7.50.
Check Out Our Latest Stock Report on Beauty Health
Beauty Health Price Performance
Shares of SKIN opened at $4.25 on Thursday. The company has a current ratio of 5.86, a quick ratio of 5.27 and a debt-to-equity ratio of 8.20. The company’s fifty day simple moving average is $3.05 and its 200 day simple moving average is $3.88. The Beauty Health Company has a 1-year low of $1.35 and a 1-year high of $13.90. The company has a market cap of $557.88 million, a price-to-earnings ratio of -6.34 and a beta of 0.94.
Beauty Health (NASDAQ:SKIN – Get Free Report) last released its quarterly earnings data on Tuesday, March 12th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.04. Beauty Health had a negative net margin of 22.26% and a negative return on equity of 5.89%. The company had revenue of $96.80 million for the quarter, compared to analyst estimates of $87.22 million. During the same period in the previous year, the business earned $0.03 EPS. Beauty Health’s revenue for the quarter was down 1.3% compared to the same quarter last year. On average, research analysts forecast that The Beauty Health Company will post -0.81 earnings per share for the current fiscal year.
Beauty Health Company Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer’s preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health.
Featured Stories
Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKIN – Free Report).
Receive News & Ratings for Beauty Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Beauty Health and related companies with MarketBeat.com’s FREE daily email newsletter.
